Khachaturian, A. S., Hayden, K. M., Mielke, M. M., Tang, Y., Lutz, M. W., Gustafson, D. R., … Khachaturian, Z. S. (2018). Future prospects and challenges for Alzheimer's disease drug development in the era of the NIA-AA Research Framework. Alzheimers Dement, 14(4), 532–534. https://doi.org/10.1016/j.jalz.2018.03.003

Khachaturian, Ara S., Kathleen M. Hayden, Michelle M. Mielke, Yi Tang, Michael W. Lutz, Deborah R. Gustafson, Walter A. Kukull, Richard Mohs, and Zaven S. Khachaturian. “Future prospects and challenges for Alzheimer's disease drug development in the era of the NIA-AA Research Framework.” Alzheimers Dement 14, no. 4 (April 2018): 532–34. https://doi.org/10.1016/j.jalz.2018.03.003.

Khachaturian AS, Hayden KM, Mielke MM, Tang Y, Lutz MW, Gustafson DR, et al. Future prospects and challenges for Alzheimer's disease drug development in the era of the NIA-AA Research Framework. Alzheimers Dement. 2018 Apr;14(4):532–4.

Khachaturian, Ara S., et al. “Future prospects and challenges for Alzheimer's disease drug development in the era of the NIA-AA Research Framework.” Alzheimers Dement, vol. 14, no. 4, Apr. 2018, pp. 532–34. Pubmed, doi:10.1016/j.jalz.2018.03.003.

Khachaturian AS, Hayden KM, Mielke MM, Tang Y, Lutz MW, Gustafson DR, Kukull WA, Mohs R, Khachaturian ZS. Future prospects and challenges for Alzheimer's disease drug development in the era of the NIA-AA Research Framework. Alzheimers Dement. 2018 Apr;14(4):532–534.